The clinical utility of the dexamethasone suppression test in psychiatry. Summary of a National Institute of Mental Health Workshop

R. M A Hirschfeld, S. H. Koslow, D. J. Kupfer

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The dexamethasone suppression test (DST) is being increasingly used in psychiatry, especially in the differential diagnosis of affective disorders. In light of this, the National Institute of Mental Health convened a workshop of clinical scientists drawn from neuroendocrinology, psychopathology, and general clinical psychiatry to review the evidence for the efficacy of the use of the DST in psychiatry. Specifically considered were DST's relevance to differential diagnosis, its use as a predictor of response to treatment, its relationship with other biologic variables, and technical issues. The panelists concluded that at this time there are no clear indications for routine use of the DST in diagnosis or clinical management of depression, although it is a useful research tool. Areas of potential utility include prediction of suicidal activity, prediction of relapse, and differential diagnosis.

Original languageEnglish (US)
Pages (from-to)2172-2174
Number of pages3
JournalJournal of the American Medical Association
Volume250
Issue number16
DOIs
StatePublished - 1983

Fingerprint

National Institute of Mental Health (U.S.)
Dexamethasone
Psychiatry
Differential Diagnosis
Education
Neuroendocrinology
Psychopathology
Mood Disorders
Depression
Recurrence
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The clinical utility of the dexamethasone suppression test in psychiatry. Summary of a National Institute of Mental Health Workshop. / Hirschfeld, R. M A; Koslow, S. H.; Kupfer, D. J.

In: Journal of the American Medical Association, Vol. 250, No. 16, 1983, p. 2172-2174.

Research output: Contribution to journalArticle

@article{dfee63a2fdcd4549814b674292e6cc56,
title = "The clinical utility of the dexamethasone suppression test in psychiatry. Summary of a National Institute of Mental Health Workshop",
abstract = "The dexamethasone suppression test (DST) is being increasingly used in psychiatry, especially in the differential diagnosis of affective disorders. In light of this, the National Institute of Mental Health convened a workshop of clinical scientists drawn from neuroendocrinology, psychopathology, and general clinical psychiatry to review the evidence for the efficacy of the use of the DST in psychiatry. Specifically considered were DST's relevance to differential diagnosis, its use as a predictor of response to treatment, its relationship with other biologic variables, and technical issues. The panelists concluded that at this time there are no clear indications for routine use of the DST in diagnosis or clinical management of depression, although it is a useful research tool. Areas of potential utility include prediction of suicidal activity, prediction of relapse, and differential diagnosis.",
author = "Hirschfeld, {R. M A} and Koslow, {S. H.} and Kupfer, {D. J.}",
year = "1983",
doi = "10.1001/jama.250.16.2172",
language = "English (US)",
volume = "250",
pages = "2172--2174",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "16",

}

TY - JOUR

T1 - The clinical utility of the dexamethasone suppression test in psychiatry. Summary of a National Institute of Mental Health Workshop

AU - Hirschfeld, R. M A

AU - Koslow, S. H.

AU - Kupfer, D. J.

PY - 1983

Y1 - 1983

N2 - The dexamethasone suppression test (DST) is being increasingly used in psychiatry, especially in the differential diagnosis of affective disorders. In light of this, the National Institute of Mental Health convened a workshop of clinical scientists drawn from neuroendocrinology, psychopathology, and general clinical psychiatry to review the evidence for the efficacy of the use of the DST in psychiatry. Specifically considered were DST's relevance to differential diagnosis, its use as a predictor of response to treatment, its relationship with other biologic variables, and technical issues. The panelists concluded that at this time there are no clear indications for routine use of the DST in diagnosis or clinical management of depression, although it is a useful research tool. Areas of potential utility include prediction of suicidal activity, prediction of relapse, and differential diagnosis.

AB - The dexamethasone suppression test (DST) is being increasingly used in psychiatry, especially in the differential diagnosis of affective disorders. In light of this, the National Institute of Mental Health convened a workshop of clinical scientists drawn from neuroendocrinology, psychopathology, and general clinical psychiatry to review the evidence for the efficacy of the use of the DST in psychiatry. Specifically considered were DST's relevance to differential diagnosis, its use as a predictor of response to treatment, its relationship with other biologic variables, and technical issues. The panelists concluded that at this time there are no clear indications for routine use of the DST in diagnosis or clinical management of depression, although it is a useful research tool. Areas of potential utility include prediction of suicidal activity, prediction of relapse, and differential diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=0020633980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020633980&partnerID=8YFLogxK

U2 - 10.1001/jama.250.16.2172

DO - 10.1001/jama.250.16.2172

M3 - Article

VL - 250

SP - 2172

EP - 2174

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 16

ER -